SCIENTIFIC HUB

Araştırmanın izini sürün.

SCIENTIFIC LITERATURE · MED

Lewy Bodies ile Demansta Multimodal Görüntüleme Uygulamaları Üzerine Karşılaştırmalı Çalışma: Görüntüleme Özelliklerinden Klinik Uygulama İmplikasyonlarına.

Comparative Study on Multimodal Imaging Applications in Dementia with Lewy Bodies: From Imaging Features to Clinical Practice Implications.

Makine çevirisi · Editoryal inceleme bekliyor

Brain Sci · 2025-11-25

DOI: 10.3390/brainsci15121264PMID: 41440061

Open accessresearch-article; Journal ArticleKaynağa git ↗

Araştırma özeti

Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by

Objective: To explore the value of multimodal molecular imaging in diagnosing and differentiating dementia with Lewy bodies (DLB). Methods: A retrospective analysis was conducted on clinical data and multimodal molecular imaging of 40 probable DLB patients treated at Peking Union Medical College Hospital (August 2017-December 2024). All 40 had 18F-FDG PET/CT; 15 had 131I-MIBG imaging; 11 had 18F-FP-CIT PET/CT. A total of 12 patients with poor cognition or atypical 18F-FDG PET/CT underwent 18F-AV45 PET/CT (2 also had 18F-PM-PBB3 imaging). A sex- and age-matched control group (cognitively normal, same-period health checkup 18F-FDG PET/CT) was included. 18F-FDG PET/CT images were visually and semi-quantitatively analyzed (ROI, SPM). 18F-AV45 PET/CT was assessed both visually and semi-quantitatively; 131I-MIBG imaging and 18F-FP-CIT PET/CT were visually evaluated. Results: The 40 DLB patients (29 males, 11 females; mean age 72 years) had distinct initial symptoms: 8 (20%) presented with cognitive decline as the first symptom, 23 (57.5%) with parkinsonian symptoms as the first symptom, and 9 (22.5%) with both symptoms occurring simultaneously. Mean intervals: 16.25 months from initial cognitive decline to parkinsonian symptoms, and 24.43 months from initial parkinsonian symptoms to cognitive decline. All had parkinsonian symptoms and cognitive impairment; 38 (95%) had visual hallucinations; and 26 (65%) had REM sleep behavior disorder. 18F-FDG PET/CT: 30(75%) showed typical occipital hypometabolism and posterior cingulate island sign; 10 (25%) had atypical findings. 131I-MIBG (15/15, 100%): cardiac sympathetic denervation. 18F-FP-CIT (10/11, 90.9%): basal ganglia dopaminergic damage. 18F-AV45 (9/12, 81.8%): positive. Semi-quantitative 18F-FDG analysis revealed parietal, occipital, and lateral temporal hypometabolism in DLB (left more severe than right). Conclusions: Dementia with Lewy bodies (DLB) presents with pre-onset parkinsonism and cognitive impairment, plus high rates of visual hallucinations and sleep disorders. Key imaging features-occipital hypometabolism/island sign on 18F-FDG PET/CT, cardiac sympathetic denervation on 131I-MIBG, and basal ganglia dopaminergic damage on 18F-FP-CIT-aid DLB diagnosis. 18F-AV45 PET/CT detects Aβ pathology in severely cognitively impaired patients, suggesting these DLB patients may have underlying AD pathology beyond DLB.

Bilimsel değerlendirme

01

Araştırma sorusu

Sorunun kapsamı orijinal çalışma üzerinden değerlendirilir.

02

Yöntem ve örneklem

Çalışma tasarımı ve örneklem için kaynak makaleyi kontrol edin.

03

Temel bulgular

Bu kayıt için editoryal olarak onaylanmış bulgu özeti henüz yayımlanmadı.

04

Sınırlılıklar

Sonuçların genellenebilirliği, yanlılık ve klinik anlamı ayrıca incelenmelidir.

Bibliyografik veriden yöntem, örneklem veya klinik sonuç çıkarımı yapılmaz.